Emsens family pre-certification of designer stanislals
| | | | | |

Emsens family: a Belgian dynasty with assets worth 2.6 billion euros

Updated on

Emsens family

SIBELCO logo controlled by Stanislas Emsens

The Emsens familyone of Belgium's richest, controls several influential multinationals, including SCR-Sibelco and Aliaxis. SCR-Sibelcospecializing in sand extraction and other minerals, has deep roots in Lommel and Dessel. Aliaxis, a building products company, is active in various markets in Europe and beyond. Etexalso associated with the Emsens family, is involved in the production of building materials such as asbestos cement. Family assets exceed 2.6 billion euros, placing the Emsens among the TOP 15 richest families in Belgium. Their influence also extends to investments in several companies, including Sofina and Solvay.

Image of the sand production of the Emsens Family

Similar Posts

Photo of Rudi Mariën in front of a mico

Rudi Mariën: Biotechnology visionary with assets of over €200 million

Rudi Mariën, a Belgian pharmacist and entrepreneur, has played a decisive role in the development of biotechnology in Belgium. Founder of Innogenetics and a key investor in numerous biotech companies, Mariën has accumulated assets of over 200 million euros. His commitment to innovation and technological development, notably through projects such as Tech Lane Ghent, continues to inspire the biotech sector worldwide.

Tans Family shopping center

Tans family: 193 million euro rise in the Belgian real estate sector

Discover the rise of the Tans family, key players in Belgian real estate, with an impressive fortune of 193 million euros. Anchored in Hasselt, the Tans Group, led by visionaries Willy, Bart and Frank Tans, dominates the real estate market thanks to strategic diversification and in-depth expertise.

photo by Dr. Paul Janssen

Dr. Paul Janssen: The Visionary Entrepreneur Behind a 300 Million Euro Fortune and a Pharmaceutical Legacy

Dr. Paul Janssen, founder of Janssen Pharmaceutica, is one of the most influential figures in the Belgian pharmaceutical industry. With a legacy estimated at over 300 million euros, Janssen revolutionized medicine with innovative medicines, while remaining a central figure in the company after its takeover by Johnson & Johnson. In addition to his medical contributions, he left a significant cultural imprint, with a unique collection of pre-Columbian art. Discover how this visionary built a pharmaceutical empire while influencing Belgian art and economics.